PharmaShots

JUNE 13, 2023

Eisai's and Merck Announces EU's Marketing Approval of Lenvima (lenvatinib mesylate) for Hepatocellular Carcinoma Published: 23 Aug,2018 | Tags: Eisai, Merck, Approval, Lenvima, HCC, 2. Pfizer to co-promote Exact Sciences Cologuard Published: 22 Aug,2018 | Tags: Exact, Pfizer, Agreement, Promote, Cologuard 7.

Labelling 52

Labelling FDA 52

pharmaphorum

JANUARY 21, 2022

Medical science is accelerating at a tremendous rate, leading to profound changes in the treatment landscape for many diseases over the last decade. “It This evolution is leading to additional health benefits and health gains, but they are accompanied by major concerns, as very high price tags raise questions about their affordability.”.

Insurance 52

Insurance Vaccines 52

Viseven

JUNE 23, 2022

What does modular content mean in Life Sciences? Along with standard content production issues like an unclear technical task, missed deadlines, or changed priorities, the price for being relevant to your audience in life sciences may cause a heart attack as the lack of standardization only creates more questions.

Communication 52

Communication 52

pharmaphorum

NOVEMBER 27, 2022

Highly exact data monitoring and modular set ups will one day allow production facilities to switch between producing a number of similar products, or alike products that use ingredients from different suppliers in minutes. Automation will be a large part of this long-term vision. About the author.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 105

The Physician Pharmacist

SEPTEMBER 14, 2023

Speaker 2 So I feel like a lot of people who get into the medical field in high school, I was always good at science and math. One is science. One is non science, one needs to be a principal investigator for a research project, one needs to be an administrator, and one needs to be a physician. So where they were getting a 4.0,

Medical Schools 52

Medical Schools Hospitals Communication Patient Care 52

Policy Prescription

APRIL 1, 2022

The investigation comes about two months after The Wall Street Journal reported on a lawsuit filed by Gilead Sciences alleging a massive breach in the U.S. What goes unstated is how much of the $78 million in drug products were legitimate and safe drugs, tagged as “unapproved” or “misbranded,” versus counterfeit drugs.

FDA 40

FDA Documentation 40